Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial.

Autor:	Chan, Dennis1,2, Binks, Sophie3, Nicholas, Jennifer M4, Frost, Chris4, Cardoso, M Jorge5, Ourselin, Sebastien5, Wilkie, David6, Nicholas, Richard6, Chataway, Jeremy7 j.chataway@ucl.ac.uk
Zdroj:	Lancet Neurology. Aug2017, Vol. 16 Issue 8, p591-600. 10p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu